Haider Warraich
speaker
683 appearances
3 recordings
1 series
first heard Oct 2020
last heard Dec 2021
Haider Warraich’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
And it takes a lot.
I mean, we diurese folks all the time, but I have seen it once.
But it was in the setting of this patient who had been, and again, maybe we hadn't explained to her, had a crate full of high salt tomato soup in her room that she's guzzling down.
While we were failing to research.
I've seen it.
I don't think it's that common.
Some people with intravenous Bumetanide drips or Pumax drips do develop this hyperalgesia syndrome that you might see in the hospital setting.
But that's probably one of the worst things I've seen.
There have been times and some centers have had success.
No, people haven't published the data
much.
So it's mostly based on just, you know, he said, she said, or my conversation with, you know, a few cardiologists.
But, you know, again, one of the things that makes hospices nervous is that, you know, they might, you know, again, hospice is paid on per diem basis.
They're worried about these prolonged costs.
But if you can tell them that, you know, we'll hang a bag of this medication and then here's a protocol that will allow you to wean this slowly over, say, a week or two weeks, that might give them more confidence to accept more patients with inotropes if that becomes a barrier.
But again, part of the whole, you know, I think communication in general is lacking, I think, especially on sort of non-cancer disease services, such as heart failure with hospice, with palliative care, et cetera.
And I think that's just another symptom of that.
at home?
So, I mean, you know, cardiologists, we are super nervous about hypokalemia.
We're like militant about it.
Showing 161–180 of 683 · page 9 of 35
← Previous
Next →